Source:http://linkedlifedata.com/resource/pubmed/id/17560278
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2007-6-11
|
pubmed:abstractText |
B-cell intrinsic immunoglobulin class switch recombination (Ig-CSR) deficiencies, previously termed hyper-IgM syndromes, are genetically determined conditions characterized by normal or elevated serum IgM levels and an absence or very low levels of IgG, IgA, and IgE. As a function of the molecular mechanism, the defective CSR is variably associated to a defect in the generation of somatic hypermutations (SHMs) in the Ig variable region. The study of Ig-CSR deficiencies contributed to a better delineation of the mechanisms underlying CSR and SHM, the major events of antigen-triggered antibody maturation. Four Ig-CSR deficiency phenotypes have been so far reported: the description of the activation-induced cytidine deaminase (AID) deficiency (Ig-CSR deficiency 1), caused by recessive mutations of AICDA gene, characterized by a defect in CSR and SHM, clearly established the role of AID in the induction of the Ig gene rearrangements underlying CSR and SHM. A CSR-specific function of AID has, however, been detected by the observation of a selective CSR defect caused by mutations affecting the C-terminus of AID. Ig-CSR deficiency 2 is the consequence of uracil-N-glycosylase (UNG) deficiency. Because UNG, a molecule of the base excision repair machinery, removes uracils from DNA and AID deaminates cytosines into uracils, that observation indicates that the AID-UNG pathway directly targets DNA of switch regions from the Ig heavy-chain locus to induce the CSR process. Ig-CSR deficiencies 3 and 4 are characterized by a selective CSR defect resulting from blocks at distinct steps of CSR. A further understanding of the CSR machinery is expected from their molecular definition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-2776
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-306
|
pubmed:meshHeading |
pubmed-meshheading:17560278-Animals,
pubmed-meshheading:17560278-B-Lymphocytes,
pubmed-meshheading:17560278-Cytidine Deaminase,
pubmed-meshheading:17560278-Humans,
pubmed-meshheading:17560278-Hyper-IgM Immunodeficiency Syndrome,
pubmed-meshheading:17560278-Immunoglobulin Class Switching,
pubmed-meshheading:17560278-Somatic Hypermutation, Immunoglobulin,
pubmed-meshheading:17560278-Uracil-DNA Glycosidase
|
pubmed:year |
2007
|
pubmed:articleTitle |
Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
|
pubmed:affiliation |
Inserm, U768, Paris F-75015, France.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|